{
  "name": "Pyruvate Kinase M2 Activator (TEPP-46)",
  "category": "supplement",
  "evidenceGrade": "D",
  "riskProfile": "medium",
  "description": "Research compound that activates pyruvate kinase M2, shifting cellular metabolism from aerobic glycolysis (Warburg effect) back to oxidative phosphorylation. Emerging interest in longevity community for metabolic reprogramming and potential anti-cancer properties.",
  "mechanisms": [
    "PKM2 tetramerization (activating glycolysis completion)",
    "Warburg effect reversal",
    "Metabolic reprogramming",
    "mTOR pathway modulation"
  ],
  "dosage": {
    "standard": "Research compound — no established human dose",
    "range": "Experimental",
    "notes": "Research-grade compound. Not commercially available as supplement. Included for awareness — represents emerging metabolic reprogramming approach."
  },
  "keyFindings": [
    "Reversed Warburg effect in cancer cells (preclinical)",
    "Improved metabolic function in aged cells in vitro",
    "Represents novel metabolic reprogramming approach to aging"
  ],
  "interactions": [
    "Unknown — research compound"
  ],
  "sideEffects": [
    "Unknown — limited safety data"
  ],
  "contraindications": [
    "Human use not established"
  ],
  "tags": [
    "experimental",
    "metabolism",
    "warburg",
    "research",
    "future"
  ],
  "estimatedMonthlyCost": {
    "low": 0,
    "mid": 0,
    "high": 0,
    "currency": "USD"
  },
  "id": "prod-pyruvate-kinase-m2-activator-tepp-46",
  "sources": [],
  "suppliers": [],
  "communityReports": [],
  "expertOpinions": [],
  "lastUpdated": "2026-02-04T14:50:14.857Z",
  "createdAt": "2026-02-04T14:50:14.857Z"
}